We just received data on a new analyst forecast for $CSGP. Mayank Tandon from Needham set a price target of 105.0 for CSGP.
To track analyst ratings and price targets for $CSGP, check out Quiver Quantitative's $CSGP forecast page.
Should you buy $CSGP?
Some analysts are better than others. To view the past performance of Needham, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CSGP Price Targets
Multiple analysts have issued price targets for $CSGP recently. We have seen 9 analysts offer price targets for $CSGP in the last 6 months, with a median target of $100.0.
Here are some recent targets:
- Mayank Tandon from Needham set a target price of $105.0 on 12/08/2025
- Jason Haas from Wells Fargo set a target price of $60.0 on 11/17/2025
- Ashish Sabadra from RBC Capital set a target price of $91.0 on 10/09/2025
- Scott Wurtzel from Wolfe Research set a target price of $105.0 on 09/03/2025
- Peter Christiansen from Citigroup set a target price of $100.0 on 07/24/2025
- Jeffrey Meuler from Baird set a target price of $105.0 on 07/23/2025
- Alexei Gogolev from JP Morgan set a target price of $101.0 on 07/23/2025
$CSGP Insider Trading Activity
$CSGP insiders have traded $CSGP stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CSGP stock by insiders over the last 6 months:
- FREDERICK G. SAINT (President, Marketplaces) has made 0 purchases and 3 sales selling 75,000 shares for an estimated $6,616,500.
- CYNTHIA CAMMETT CANN (Chief Accounting Officer) has made 0 purchases and 2 sales selling 3,874 shares for an estimated $315,406.
- JOHN W HILL sold 2,250 shares for an estimated $154,530
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CSGP Revenue
$CSGP had revenues of $833.6M in Q3 2025. This is an increase of 20.36% from the same period in the prior year.
You can track CSGP financials on Quiver Quantitative's CSGP stock page.
$CSGP Congressional Stock Trading
Members of Congress have traded $CSGP stock 10 times in the past 6 months. Of those trades, 9 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CSGP stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 8 times. They made 8 purchases worth up to $155,000 on 10/15, 09/30, 09/22, 07/31, 07/09, 06/30, 06/27, 06/25 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/13 and 1 sale worth up to $15,000 on 09/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CSGP Hedge Fund Activity
We have seen 470 institutional investors add shares of $CSGP stock to their portfolio, and 435 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 8,030,862 shares (-54.2%) from their portfolio in Q3 2025, for an estimated $677,563,826
- TOMS CAPITAL INVESTMENT MANAGEMENT LP removed 3,508,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $282,043,200
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,983,613 shares (-45.9%) from their portfolio in Q3 2025, for an estimated $251,727,428
- NUVEEN, LLC added 2,424,722 shares (+224.1%) to their portfolio in Q3 2025, for an estimated $204,573,795
- JANUS HENDERSON GROUP PLC added 2,180,980 shares (+54.0%) to their portfolio in Q3 2025, for an estimated $184,009,282
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,937,522 shares (+65.0%) to their portfolio in Q3 2025, for an estimated $163,468,731
- CITADEL ADVISORS LLC added 1,695,175 shares (+5391.3%) to their portfolio in Q3 2025, for an estimated $143,021,914
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
